US PTAB Patent Cases
8,722 decisions indexed
Page 77 of 291 · 8,722 total
SAMSUNG ELECTRONICS CO., LTD. et al. v.OMNI MEDSCI, INC.
Apple prevailed in an IPR against Omni MedSci’s wearable health‑monitoring patent, finding 12 of the 23 claims unpatentable while the remaining claims survived.
SAMSUNG ELECTRONICS CO., LTD. et al. v.OMNI MEDSCI, INC.
Apple has filed an IPR petition challenging Omni MedSci’s ’533 wearable health‑monitoring patent, arguing that all asserted claims are obvious over prior‑art references Lisogurski, Carlson and Mannheimer.
SAMSUNG ELECTRONICS CO., LTD. et al. v.OMNI MEDSCI, INC.
Samsung (on behalf of Apple) petitions the PTAB to invalidate Omni MedSci’s 9,651,533 patent covering wearable optical health monitors. The petition asserts obviousness over Lisogurski, Carlson, and Mannheimer references and requests that the trial be instituted.
SAMSUNG ELECTRONICS CO., LTD. et al. v.OMNI MEDSCI, INC.
Apple has filed an IPR petition seeking to invalidate Omni MedSci’s ’484 wearable health‑monitoring patent. The petition relies on a combination of five prior‑art references to argue obviousness of all 23 claims. The case is pending institution.
SAMSUNG ELECTRONICS CO., LTD. et al. v.OMNI MEDSCI, INC.
Apple (as petitioner) prevailed in an IPR against Omni MedSci’s 9,651,533 patent, with the PTAB finding all challenged claims unpatentable as obvious over Lisogurski, Carlson, and Mannheimer. The decision hinges on pulse‑rate and signal‑to‑noise teachings in the prior art.
Apple Inc. v.Telcom Ventures LLC
Apple Inc. filed a motion to dismiss its IPR petition against Telcom Ventures' U.S. Patent 12,028,793, arguing that the Board has not yet ruled on institution and that proceeding would waste resources. The motion seeks pre‑institution dismissal while other related IPRs remain active in parallel litigation.
Apple Inc. v.Telcom Ventures LLC
Apple filed a motion to dismiss its IPR against Telcom Ventures’ U.S. Patent 11,770,756, arguing that the case is pre‑institution and that dismissal will conserve resources. The Board has not yet ruled on institution.
Apple Inc. v.Telcom Ventures LLC
Apple filed a motion to dismiss its IPR petition against Telcom Ventures' 9,462,411 patent, citing good cause and the early stage of the proceeding. The Board has not yet ruled on institution.
BOE Technology Group Co., Ltd. v.Paneltouch Technologies LLC
BOE Technology and Paneltouch Technologies have settled their dispute over U.S. Patent 11,126,025 and jointly moved to terminate the IPR proceeding.
SAMSUNG ELECTRONICS CO., LTD. et al. v.OMNI MEDSCI, INC.
Court decision.
SAMSUNG ELECTRONICS CO., LTD. et al. v.OMNI MEDSCI, INC.
Samsung has filed a PGR petition seeking to invalidate Omni MedSci’s wearable health‑monitoring patent (12,268,475) on obviousness grounds, relying on prior art such as Lisogurski, Tran, LeBoeuf and Carlson.
SAMSUNG ELECTRONICS CO., LTD. et al. v.OMNI MEDSCI, INC.
Samsung and co‑petitioners have filed a PGR seeking to invalidate claim 7 of Omni MedSci’s 12,193,790 patent, arguing obviousness over Lisogurski and Carlson and invoking collateral estoppel from earlier IPRs.
Samsung Electronics Co., Ltd. et al. v.Radian Memory Systems LLC
Samsung Electronics has filed an IPR petition challenging Radian Memory Systems’ ’995 patent covering flash‑memory address translation. The petition relies on Reiter, SCSI standards, Sinclair‑367 and Yamada to argue obviousness of 23 claims.
Samsung Electronics Co., Ltd. et al. v.Radian Memory Systems LLC
Samsung has filed an IPR petition challenging Radian’s ’657 patent covering flash memory address translation, asserting that the claims are obvious over prior‑art flash controllers and SCSI standards.
Samsung Electronics Co., Ltd. et al. v.Radian Memory Systems LLC
Samsung has filed an IPR petition challenging all 23 claims of Radian’s ’656 flash‑memory controller patent, asserting obviousness over Reiter, SCSI standards and other prior art. The petition outlines five statutory grounds under 35 U.S.C. §103. The proceeding is currently at the petition stage.
Regions Bank v.United Services Automobile Association
Regions Bank has filed an IPR petition seeking cancellation of all 30 claims of US Patent 12,211,095, which covers mobile check‑deposit functionality. The petition alleges obviousness over multiple prior‑art references spanning mobile imaging, APIs, and OCR. The Board has yet to decide whether to institute the review.
Red Hat, Inc. v.Competitive Access Systems, Inc.
Red Hat has filed an IPR petition seeking cancellation of claims 1‑3 of Competitive Access Systems’ ’641 patent covering residential bandwidth‑aggregation gateways, arguing the claims are obvious over two prior‑art references.
SAMSUNG ELECTRONICS CO., LTD. et al. v.OMNI MEDSCI, INC.
Samsung and co‑petitioners have filed an IPR petition challenging Omni MedSci’s wearable health‑monitoring patent, asserting obviousness over multiple prior‑art references and invoking collateral estoppel from earlier IPRs.
Microsoft Corporation v.Dialect, LLC
Microsoft has filed an IPR petition challenging claim 42 of Dialect’s ’659 patent, asserting lack of written description support and obviousness over multiple prior‑art references. The petition seeks institution of the review to invalidate the claim.
SAMSUNG ELECTRONICS CO., LTD. et al. v.OMNI MEDSCI, INC.
Samsung and co‑petitioners seek an IPR of Omni MedSci’s ’455 wearable health‑monitoring patent, arguing the claims are obvious over prior art and that earlier IPR findings estop re‑litigation. They request the Board institute the proceeding.
BOE Technology Group Co., Ltd. v.Paneltouch Technologies LLC
BOE Technology Group has filed an IPR petition challenging Paneltouch Technologies' 11,126,025 patent covering in‑cell LCD touch panels, asserting that the claims are obvious over prior‑art references Kim, Kim II and Yoshida.
SAMSUNG ELECTRONICS CO., LTD. et al. v.OMNI MEDSCI, INC.
Samsung and co‑petitioners have filed an IPR petition against Omni MedSci’s U.S. Patent 12,193,790, asserting that claim 7 is obvious over Lisogurski and Carlson references and should be barred by collateral estoppel.
SAMSUNG ELECTRONICS CO., LTD. et al. v.OMNI MEDSCI, INC.
Samsung and co‑petitioners have filed an IPR petition against Omni MedSci’s 9,651,533 patent, asserting that the dependent claims are obvious over prior art references Lisogurski, Carlson and Tam. They seek institution of the review and a finding of unpatentability under §103.
Apple Inc. v.Telcom Ventures LLC
Apple has filed an IPR petition seeking cancellation of all 11 claims of Telcom Ventures’ ’793 patent, which covers adaptive NFC‑based payment functions. The petition relies on obviousness arguments over a combination of prior‑art patents and the ISO‑14443 standard.
Apple Inc. v.Telcom Ventures LLC
Apple has filed an IPR petition seeking cancellation of all 17 claims of Telcom Ventures’ U.S. Patent 10,674,432, arguing they are obvious over a suite of prior‑art NFC and biometric references. The petition lists eight grounds covering the full claim set.
Apple Inc. v.Telcom Ventures LLC
Apple has filed a petition to cancel all 18 claims of Telcom Ventures' U.S. Patent 11,770,756, alleging obviousness over multiple prior‑art references. The petition outlines six grounds invoking 35 U.S.C. § 103 and seeks full cancellation of the patent.
Apple Inc. v.Telcom Ventures LLC
Apple has filed an IPR petition seeking cancellation of all 19 claims of Telcom Ventures’ ’708 patent, arguing they are obvious over Carlson, ISO‑14443, Jazayeri and Birch references.
Apple Inc. v.Telcom Ventures LLC
Apple has filed an IPR petition seeking cancellation of claims 1‑4 of Telcom Ventures’ ’411 patent, alleging obviousness over prior‑art NFC payment systems combined with biometric authentication. Two grounds are presented, differing on the interpretation of “physiological data.”
Red Hat, Inc. v.Competitive Access Systems, Inc.
Red Hat petitions the PTAB to invalidate Competitive Access Systems’ 8,228,801 patent, asserting that all 17 claims are obvious over earlier bandwidth‑sharing technologies. The petition relies on the Challener and Kotzin disclosures, with Held providing motivation for routing‑table features.
SAMSUNG ELECTRONICS CO., LTD. et al. v.OMNI MEDSCI, INC.
Samsung and co‑petitioners have filed an IPR seeking to invalidate Omni MedSci’s U.S. Pat. 9,055,868, arguing the claims are obvious over multiple prior‑art references covering optical diagnostic systems.
Dealing with a patent challenge?
Whether it's a Section 3(d) rejection, a post-grant opposition, or a FRAND dispute, Arctic's patent litigation team has handled it. Get a strategy call.